These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6157375)

  • 1. Antineuraminidase antibody response to vaccination of chickens with intact virus and different submit preparations of the influenza virus strains A/Sing/1/57 (H2N2), A/Hong Kong/1/68 (H3N2) and A/Port Chalmers/1/73 (H3N2).
    Drescher J; Desselberger U
    Arch Virol; 1980; 64(3):235-46. PubMed ID: 6157375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the antineuraminidase antibody response to vaccination with intact virus and subunit preparations obtained by different techniques of the influenza virus strains A/Sing/1/57 (H2N2), A/Hong Kong/1/68 (H3N2) and A/Port Chalmers/1/73 (H3N2).
    Drescher J; Desselberger U
    Comp Immunol Microbiol Infect Dis; 1980; 3(1-2):219-23. PubMed ID: 6162604
    [No Abstract]   [Full Text] [Related]  

  • 3. Description of a technique for the analysis of antineuraminidase antibodies oriented to H2N2 and H3N2 influenza virus strains.
    Drescher J
    Arch Virol; 1978; 56(1-2):135-47. PubMed ID: 564681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation-conditioned changes of the antigenicity of influenza virus neuraminidases.
    Desselberger U
    Arch Virol; 1977; 53(4):335-49. PubMed ID: 68766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of reactions of antihemagglutinin and antineuraminidase antibodies with H2N2 and H3N2 influenza virus strains and description of a modification of the photometric ACU method for titration of antineuraminidase antibodies.
    Drescher J; Desselberger U
    Arch Virol; 1976; 50(1-2):97-107. PubMed ID: 1259594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunogenicity of live influenza viruses and their solubilized neuraminidases: results of mouse protection experiments.
    Bottex C; Burckhart MF; Fontanges R
    Arch Virol; 1981; 70(2):83-9. PubMed ID: 7332493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-protection in mice after immunization with H2N2, H3N2, and Heq2Neq2 influenza virus strains.
    Anker WJ; Bakker AK; Masurel N
    Infect Immun; 1978 Jul; 21(1):96-101. PubMed ID: 711325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on strain-specific and common antigen antihemagglutinin antibodies oriented to the influenza virus H3N2 strains A/Hong Kong/1/68 and A/Port Chalmers/1/73.
    Drescher J; Verhagen W
    Infect Immun; 1978 Sep; 21(3):792-7. PubMed ID: 81808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of the antibody response to the different antigenic determinants on the hemagglutinin subunits of influenza viruses.
    Laver WG; Downie JC; Webster RG
    J Immunol; 1976 Feb; 116(2):336-41. PubMed ID: 55438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic variation of neuraminidase of human type A influenza (H3N2) viruses isolated in Berlin (West).
    Werner J; Schudrowitz C; Köhler H
    Zentralbl Bakteriol Orig A; 1975 Dec; 233(4):440-6. PubMed ID: 56831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus.
    Schild GC; Oxford JS; Dowdle WR; Coleman M; Pereira MS; Chakraverty P
    Bull World Health Organ; 1974; 51(1):1-11. PubMed ID: 4218138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain.
    Wan H; Gao J; Yang H; Yang S; Harvey R; Chen YQ; Zheng NY; Chang J; Carney PJ; Li X; Plant E; Jiang L; Couzens L; Wang C; Strohmeier S; Wu WW; Shen RF; Krammer F; Cipollo JF; Wilson PC; Stevens J; Wan XF; Eichelberger MC; Ye Z
    Nat Microbiol; 2019 Dec; 4(12):2216-2225. PubMed ID: 31406333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses.
    Tamura M; Webster RG; Ennis FA
    J Virol; 1994 Jun; 68(6):3499-504. PubMed ID: 8189489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the antigenicity of influenza virus neuraminidases due to various methods of preparation].
    Desselberger U
    Fortschr Med; 1978 Mar; 96(9):471-6. PubMed ID: 627393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influenza vaccine stimulation of antibodies to different variants of influenza A virus].
    Naĭkhin AN; Ispolatova AV; Tsybul'skaia NV; Sominina AA; Denisov GM
    Vopr Virusol; 1985; 30(3):290-6. PubMed ID: 4049840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of antineuraminidase antibodies in resistance to influenza A and immunologic memory for their synthesis.
    Naikhin AN; Tsaritsina IM; Oleinikova EV; Syrodoeva LG; Korchanova NL; Denisov GM; Shvartsman YaS
    J Hyg (Lond); 1983 Aug; 91(1):131-8. PubMed ID: 6886409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of an influenza virus, similar to A/Port Chalmers/1/73 (H3N2) from a common murre at Sakhalin Island in U.S.S.R. (Strain A/common murre/Sakhalin/1/74).
    Sazonov AA; Lvov DK; Webster RG; Sokolova TV; Braude NA; Portyanko NV
    Arch Virol; 1977; 53(1-2):1-7. PubMed ID: 851395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection.
    Oxford JS; Haaheim LR; Slepushkin A; Werner J; Kuwert E; Schild GC
    J Hyg (Lond); 1981 Feb; 86(1):17-26. PubMed ID: 7462596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strain specificity of the antineuraminidase antibodies of influenza virus serotype N2 strains in convalescents].
    Molibog EV; Konstantinov-Zibelist I; Starke G; Zakstel'skaia LIa
    Vopr Virusol; 1979; (6):631-4. PubMed ID: 524860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.